TDP1-independent pathways in the process and repair of TOP1-induced DNA damage.
Huimin ZhangYun XiongDan SuChao WangMrinal SrivastavaMengfan TangXu FengMin HuangZhen ChenJunjie ChenPublished in: Nature communications (2022)
Anticancer drugs, such as camptothecin (CPT), trap topoisomerase I (TOP1) on DNA and form TOP1 cleavage complexes (TOP1cc). Alternative repair pathways have been suggested in the repair of TOP1cc. However, how these pathways work with TDP1, a key repair enzyme that specifically hydrolyze the covalent bond between TOP1 catalytic tyrosine and the 3'-end of DNA and contribute to the repair of TOP1cc is poorly understood. Here, using unbiased whole-genome CRISPR screens and generation of co-deficient cells with TDP1 and other genes, we demonstrate that MUS81 is an important factor that mediates the generation of excess double-strand breaks (DSBs) in TDP1 KO cells. APEX1/2 are synthetic lethal with TDP1. However, deficiency of APEX1/2 does not reduce DSB formation in TDP1 KO cells. Together, our data suggest that TOP1cc can be either resolved directly by TDP1 or be converted into DSBs and repaired further by the Homologous Recombination (HR) pathway.
Keyphrases
- amyotrophic lateral sclerosis
- induced apoptosis
- dna damage
- cell cycle arrest
- genome wide
- dna repair
- oxidative stress
- endoplasmic reticulum stress
- signaling pathway
- circulating tumor
- cell free
- single molecule
- cell death
- high throughput
- crispr cas
- dna methylation
- drug induced
- diabetic rats
- endothelial cells
- big data
- smoking cessation
- transcription factor